Posted by Michael Wonder on 21 Apr 2020
Launch of enhanced monitoring system for availability of medicines used for treating COVID-19
21 April 2020 - EMA, together with the pharmaceutical industry and the EU Member States, has launched its enhanced fast-track monitoring system to help prevent and mitigate supply issues with crucial medicines used for treating patients with COVID-19.
Under this system, each pharmaceutical company will appoint a single contact point (an industry single point of contact, or i-SPOC) who will report to EMA and national competent authorities all current and anticipated shortages of medicines used in patients with COVID-19, both for centrally and nationally authorised medicines.
